Cargando…

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B

Overexpression of the Dual-specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) gene contributes to the retardation, craniofacial anomalies, cognitive impairment, and learning and memory deficits associated with Down Syndrome (DS). DCAF7/HAN11/WDR68 (hereafter WDR68) binds DYRK1A and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yousefelahiyeh, Mina, Xu, Jingyi, Alvarado, Estibaliz, Yu, Yang, Salven, David, Nissen, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264848/ https://www.ncbi.nlm.nih.gov/pubmed/30496304 http://dx.doi.org/10.1371/journal.pone.0207779

Ejemplares similares

Wdr68 Mediates Dorsal and Ventral Patterning Events for Craniofacial Development
por: Alvarado, Estibaliz, et al.
Publicado: (2016)

Wdr68 Requires Nuclear Access for Craniofacial Development
por: Wang, Bingyan, et al.
Publicado: (2013)

A complex between DYRK1A and DCAF7 phosphorylates the C-terminal domain of RNA polymerase II to promote myogenesis
por: Yu, Dan, et al.
Publicado: (2019)

The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2
por: Glenewinkel, Florian, et al.
Publicado: (2016)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Ocular Phenotype Associated with DYRK1A Variants
por: Méjécase, Cécile, et al.
Publicado: (2021)

A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay
por: Lee, Kyu-Sun, et al.
Publicado: (2020)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
por: Ashford, Anne L., et al.
Publicado: (2015)

Clinical phenotype of ASD-associated DYRK1A haploinsufficiency
por: Earl, Rachel K., et al.
Publicado: (2017)

Dyrk1 inhibition improves Alzheimer's disease‐like pathology
por: Branca, Caterina, et al.
Publicado: (2017)

The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species
por: Deng, Xiaobing, et al.
Publicado: (2014)

DYRK1A activates NFATC1 to increase glioblastoma migration
por: Liu, Heng, et al.
Publicado: (2021)

DYRK1-mediated phosphorylation of endocytic components is required for extracellular lumen expansion in ascidian notochord
por: Ouyang, Xiuke, et al.
Publicado: (2023)

One-carbon cycle alterations induced by Dyrk1a dosage
por: Delabar, Jean-Maurice, et al.
Publicado: (2014)

Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
por: Chen, Hua, et al.
Publicado: (2017)

Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
por: Dirice, Ercument, et al.
Publicado: (2016)

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression
por: Li, Lei, et al.
Publicado: (2021)

FastGrow: on-the-fly growing and its application to DYRK1A
por: Penner, Patrick, et al.
Publicado: (2022)

Dual inhibition of HSF1 and DYRK2 impedes cancer progression
por: Tandon, Vasudha, et al.
Publicado: (2023)

NFATc1 phosphorylation by DYRK1A increases its protein stability
por: Liu, Heng, et al.
Publicado: (2017)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
por: Janel, N, et al.
Publicado: (2017)

DYRK1A Controls HIV-1 Replication at a Transcriptional Level in an NFAT Dependent Manner
por: Booiman, Thijs, et al.
Publicado: (2015)

Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
por: Deng, Xiaobing, et al.
Publicado: (2014)

Plasma DYRK1A as a novel risk factor for Alzheimer's disease
por: Janel, N, et al.
Publicado: (2014)

Selective inhibition of the kinase DYRK1A by targeting its folding process
por: Kii, Isao, et al.
Publicado: (2016)

Small Molecule Inhibitors of DYRK1A Identified by Computational and Experimental Approaches
por: Yoon, Hye Ree, et al.
Publicado: (2020)

[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors
por: Lechner, Christian, et al.
Publicado: (2019)

Case Report: Gut and spleen anomalies associated with DYRK1A syndrome
por: Infantino, I., et al.
Publicado: (2023)

Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice
por: Postic, Guillaume, et al.
Publicado: (2023)

Identification of Suppressors of mbk-2/DYRK by Whole-Genome Sequencing
por: Wang, Yuemeng, et al.
Publicado: (2013)

Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control
por: Singh, Rajeev, et al.
Publicado: (2017)

The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities
por: Boni, Jacopo, et al.
Publicado: (2020)

Natural Aristolactams and Aporphine Alkaloids as Inhibitors of CDK1/Cyclin B and DYRK1A
por: Marti, Guillaume, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_15ta1m93j5hj41n5fq4ldt0gf6